Development of a novel methodology for cryopreservation of melanoma cells applied to CSF470 therapeutic vaccine

CSF470 vaccine is a mixture of four lethally irradiated melanoma cell lines, administered with BCG and GM-CSF, which is currently being tested in a Phase II/III Clinical trial in stage II/III melanoma patients. To prepare vaccine doses, irradiated melanoma cell lines are frozen using dimethyl sulfox...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Tapia, I.J
Otros Autores: Aris, M., Arriaga, J.M, Blanco, P.A, Mazzobre, F., Vega, J., Mordoh, J., Barrio, M.M
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2013
Materias:
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
Descripción
Sumario:CSF470 vaccine is a mixture of four lethally irradiated melanoma cell lines, administered with BCG and GM-CSF, which is currently being tested in a Phase II/III Clinical trial in stage II/III melanoma patients. To prepare vaccine doses, irradiated melanoma cell lines are frozen using dimethyl sulfoxide (Me2SO) and stored in liquid nitrogen (liqN2). Prior to inoculation, doses must be thawed, washed to remove Me2SO and suspended for clinical administration. Avoiding the use of Me2SO and storage in liqN2 would allow future freeze-drying of CSF470 vaccine to facilitate pharmaceutical production and distribution. We worked on the development of an alternative cryopreservation methodology while keeping the vaccine's biological and immunogenic properties. We tested different freezing media containing trehalose suitable to remain as excipients in a freeze-dried product, to cryopreserve melanoma cells either before or after gamma irradiation. Melanoma cells incorporated trehalose after 5h incubation at 37°C by fluid-phase endocytosis, reaching an intracellular concentration that varied between 70-140mM depending on the cell line. Optimal freezing conditions were 0.2M trehalose and 30mg/ml human serum albumin, at -84°C. Vaccine doses could be frozen in trehalose at -84°C for at least four months keeping their cellular integrity, antigen expression and apoptosis/necrosis profile after gamma-irradiation as compared to Me2SO control. Non-irradiated melanoma cell lines also showed comparable proliferative capacity after both cryopreservation procedures. Trehalose-freezing medium allowed us to cryopreserve melanoma cells, either alive or after gamma irradiation, at -84°C avoiding the use of Me2SO and liqN2 storage. These cryopreservation conditions could be suitable for future freeze-drying of CSF470 vaccine. © 2013 Elsevier Inc.
Bibliografía:Barrio, M.M., Abes, R., Colombo, M., Pizzurro, G., Boix, C., Roberti, M.P., Gélizé, E., Teillaud, J.L., Human macrophages and dendritic cells can equally present MART-1 antigen to CD8(+) T cells after phagocytosis of gamma-irradiated melanoma cells (2012) PLoS One, 7, pp. e40311
Barrio, M.M., Tshurl de Motta, P., Kaplan, J., von Euw, E.M., Bravo, A.I., Chacón, R.D., Mordoh, J., A phase I study of an allogeneic cell vaccine (VACCIMEL) with GM-CSF in melanoma patients (2006) J. Immunother., 29, pp. 444-454
Buchanan, S.S., Pyatt, D.W., Carpenter, J.F., Preservation of differentiation and clonogenic potential of human hematopoietic stem and progenitor cells during lyophilization and ambient storage (2010) PLoS One, 5 (9), pp. e12518
Campbell, L.H., Brockbank, K.G., Culturing with trehalose produces viable endothelial cells after cryopreservation (2012) Cryobiology, 64, pp. 240-244
Coulie, P.G., Brichard, V., Van Pel, A., Wölfel, T., Schneider, J., Traversari, C., Mattei, S., Boon, T., A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas (1994) J. Exp. Med., 180, pp. 35-42
Crowe, J.H., Carpenter, J.F., Crowe, L.M., The role of vitrification in anhydrobiosis (1998) Annu. Rev. Physiol., 60, pp. 73-103
Crowe, J.H., Crowe, L.M., Carpenter, J.F., Rudolph, A.S., Wistrom, C.A., Spargo, B.J., Anchordoquy, T.J., Interactions of sugars with membranes (1988) Biochem. Biophys. Acta, 947, pp. 367-384
Freimoser, F.M., Jakob, C.A., Aebi, M., Tuor, U., The MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay is a fast and reliable method for colorimetric determination of fungal cell densities (1999) Appl. Environ. Microbiol., 65, pp. 3727-3729
Geeraedts, F., Saluja, V., ter Veer, W., Amorij, J.P., Frijlink, H.W., Wilschut, J., Hinrichs, W.L., Huckriede, A., Preservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperatures (2010) AAPS J., 12, pp. 215-222
Gläfke, C., Akhoondi, M., Oldenhof, H., Sieme, H., Wolkers, W.F., Cryopreservation of platelets using trehalose: the role of membrane phase behavior during freezing (2012) Biotechnol. Prog., 28, pp. 1347-1354
Goldszmid, R.S., Idoyaga, J., Bravo, A.I., Steinman, R., Mordoh, J., Wainstok, R., Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma (2003) J. Immunol., 171, pp. 5940-5947
Karlsson, J.O.M., Toner, M., Long term storage of tissues by cryopreservation: critical issues (1996) Biomaterials, 17, pp. 243-256
Kawakami, Y., Eliyahu, S., Delgado, C.H., Robbins, P.F., Rivoltini, L., Topalian, S.L., Miki, T., Rosenberg, S.A., Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor (1994) Proc. Natl. Acad. Sci., 91, pp. 3515-3519
Kawakami, Y., Eliyahu, S., Delgado, C.H., Robbins, P.F., Sakaguchi, K., Appella, E., Yannelli, J.R., G.JAdema, T.Miki, S.A.Rosenberg, Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection (1994) Proc. Natl. Acad. Sci., 91, pp. 6458-6462
Kelvin, G.M., Campbell, L.H., Ratcliff, K.M., Sarver, K.A., (2002) Method for treatment of cellular material with sugars prior to preservation, , US patent #7,270,946
Kudo, T., Takeuchi, K., Ebina, Y., Nakazawa, M., Inhibitory effects of trehalose on malignant melanoma cell growth: implications for a novel topical anticancer agent on the ocular surface (2012) ISRN Ophthalmology 2012, , Article ID 968493, 9. pagesdoi:10.5402/2012/968493
Lang, R., Winter, G., Vogt, L., Zurcher, A., Dorigo, B., Schimmele, B., Rational design of a stable freeze-dried virus-like particle-based vaccine formulation (2009) Drug Dev. Ind. Pharm., 35, pp. 83-97
Laurentin, A., Edwards, C.C., A microtiter modification of the anthrone-sulfuric acid colorimetric assay for glucose-based carbohydrates (2003) Anal. Biochem., 315, pp. 143-145
Lloyd, T.D., Orr, S., Skett, P., Berry, D.P., Denninson, A.R., Cryopreservation of hepatocytes: a review of current methods for banking (2003) Cell Tissue Bank, 4, pp. 3-15
Mazur, P., Cryobiology: the freezing of biological systems (1970) Science, 168, pp. 939-949
Mazur, P., Freezing of living cells: mechanisms and implications (1984) Am. J. Physiol., 247, pp. C125-C142
Oliver, A.E., Jamil, K., Crowe, J.H., Tablin, F., Loading human mesenchymal stem cells with trehalose by fluid-phase endocytosis (2004) Cell Preserv. Technol., 2, pp. 35-49
Rodrigues, J.P., Paraguassú-Braga, F.H., Carvalho, L., Abdelhay, E., Bouzas, L.F., Porto, L.C., Evaluation of trehalose and sucrose as cryoprotectants for hematopoietic stem cells of umbilical cord blood (2008) Cryobiology, 56, pp. 144-151
Schebor, C., Mazzobre, M.F., Buera, M.P., Glass transition and time-dependent crystallization behavior of dehydration bioprotectant sugars (2010) Carbohydr. Res., 345, pp. 303-308
Tai, T., Cahan, L.D., Tsuchida, T., Saxton, R.E., Irie, R.F., Morton, D.L., Immunogenicity of melanoma-associated gangliosides in cancer patients (1985) Int. J. Cancer, (5), pp. 607-612
von Euw, E.M., Barrio, M.M., Furman, D., Bianchini, M., Levy, E.M., Yee, C., Li, Y., Mordoh, J., Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes (2007) J. Transl. Med., 20, p. 19
von Euw, E.M., Barrio, M.M., Furman, D., Levy, E.M., Bianchini, M., Peguillet, I., Lantz, O., Mordoh, J., A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression (2008) J. Transl. Med., 6, p. 6
Wikström, J., Elomaa, M., Nevala, L., Räikkönen, J., Heljo, P., Urtti, A., Yliperttula, M., Viability of freeze dried microencapsulated human retinal pigment epithelial cells (2012) Eur. J. Pharm. Sci., 47, pp. 520-526
Wolfe, J., Bryant, G., Freezing, drying, and /or vitrification of membrane-solute water systems (1999) Cryobiology, 39, pp. 103-109
Wolkers, W.F., Loopera, S.A., Fontanilla, R.A., Tsvetkova, N.M., Tablin, F., Crowe, J.H., Temperature dependence of fluid phase endocytosis coincides with membrane properties of pig platelets (2003) Biochimica et Biophysica Acta, 1612, pp. 154-163
Wolkers, W.F., Walker, N.J., Tablin, F., Crowe, J.H., Human platelets loaded with trehalose survive freeze-drying (2001) Cryobiology, 42, pp. 79-87
Wright, D.L., Eroglu, A., Toner, M., Toth, T.L., Use of sugars in cryopreserving human oocytes (2004) Reprod. Biomed. Online, 9 (2), pp. 179-186
https://register.clinicaltrials.gov/prs/app/action/SelectProtocol?sid=S0003VL3&selectaction=View&uid=U0001TJV&ts=8&cx=gvgb80, ClinicalTrials.gov: CASVAC0401 registered at
ISSN:00112240
DOI:10.1016/j.cryobiol.2013.06.007